Despite the availability of an increasing variety of disease‐modifying therapies, the proportion of patients with generalized myasthenia gravis ( MG ) who achieved the practical treatment goal remained low at approximately 50%‐60% in our latest survey. Therefore, there is a need for further ...
A doctor who treats myasthenia gravis patients details how treatment has evolved and how new treatment options have affected management of the condition. Video A Team of Experts With a chronic disease like myasthenia gravis, you may see several specialists, from a neurologist and ophthalmologist to ...
Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study Thymomas occurring in myasthenia gravis (MG) are usually of the cortical subtype and are usually treated by thymectomy. However, the factors that influence... F Romi,NE Gilhus,JE Varhaug,... - 《European...
Myasthenia gravis (MG) is estimated to affect as many as 60,000 patients in the United States and more than 700,000 people worldwide. In approximately 10% of patients, complications can be life-threatening. However, with the right treatment, MG can be a manageable disease, and patients can...
Stimulated by the successful introduction of interferon-β as treatment for relapsing-remitting multiple sclerosis (MS) and based on an improved knowledge of the immunopathology of MS, a vast array of treatment options is currently under investigation for disease course modification. These are targeting...
These include tendinosis, Fibromyalgia syndrome, mitochondrial myopathy, tetanus, muscular dystrophy, and myasthenia gravis. What are the symptoms of muscular system diseases? There are many different symptoms of muscular disease. These may include muscle weakness, rigidity, loss of muscle control, ...
tests to cross-check any symptoms you've described. One common test, known as an autoantibody screen, looks for antibodies that are attacking your own tissues (autoantibodies). While the presence of autoantibodies in your blood isn’t enough to confirm an autoimmune disease diagnosis, it's a ...
Introduction Inter-individual variation in drug efficacy and tolerability in myasthenia gravis (MG), an autoimmune disorder mostly treated by chronic immunosuppression, highlights the need of specific, safe and tailored precision medicine approaches. By targeting the disease-effector molecules, biological ...
Vidarsson, B., Mosher, D. F., Salamat, M. S., Isaksson, H. J. & Onundarson, P. T. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.Am. J. Hematol.70, 51–54 (2002). ...
To look for clinical trials in your area, search for “age-related macular degeneration” at www.clinicaltrials.gov. SourcesUpdate History Share Print Save View privacy policy, copyright and trust info Next Article Guide to Myasthenia Gravis...